TRANSCONTINENTAL REALTY INVESTORS INC (TCI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q2 '18: 125.1M Q3 '18: 127.1M Q4 '18: 149.1M Q1 '19: 130M Q2 '19: 110.2M Q3 '19: 90.1M Q4 '19: 43.5M Q1 '20: 44.3M Q2 '20: 45.9M Q3 '20: 44.7M Q4 '20: 57M Q1 '21: 56.1M Q2 '21: 53.5M Q3 '21: 51.3M Q4 '21: 40.8M Q1 '22: 36.7M Q2 '22: 33.7M Q3 '22: 32M Q4 '22: 36.7M Q1 '23: 40.6M Q2 '23: 45M Q3 '23: 49.2M Q4 '23: 49.9M Q1 '24: 50.1M Q2 '24: 49.6M Q3 '24: 48.7M Q4 '24: 47.1M Q1 '25: 47.2M Q2 '25: 47.6M Q3 '25: 48.8M Q4 '25: 49.1M Q1 '26: 49.4M Q2 '26: 50.1M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-21M -14M -7M 0 7M 14M 21M Q4 '11: -32K Q1 '12: -24.3K Q2 '12: -4.9M Q3 '12: -7.6M Q4 '12: 9.2M Q1 '13: 9.2M Q2 '13: 12M Q3 '13: 13.1M Q4 '13: -6.5M Q1 '14: -5.5M Q2 '14: -8.2M Q3 '14: -8.2M Q4 '14: 771K Q1 '15: 2.9M Q2 '15: 7.2M Q3 '15: 8.9M Q4 '15: 9.3M Q1 '16: 10.3M Q2 '16: 11.7M Q3 '16: 13.1M Q4 '16: 17.6M Q1 '17: 18.8M Q2 '17: 18.8M Q3 '17: 20.3M Q4 '17: 20.1M Q1 '18: 20.1M Q2 '18: 18.9M Q3 '18: 18.9M Q4 '18: 16.1M Q1 '19: 9.7M Q2 '19: 1.7M Q3 '19: -3.7M Q4 '19: -12.2M Q1 '20: -14.1M Q2 '20: -10.1M Q3 '20: -12.1M Q4 '20: -25K Q1 '21: 895K Q2 '21: -5M Q3 '21: -8M Q4 '21: -16.2M Q1 '22: -18.1M Q2 '22: -15.7M Q3 '22: -13.9M Q4 '22: -9.3M Q1 '23: -7.7M Q2 '23: -8.4M Q3 '23: -7.4M Q4 '23: -10M Q1 '24: -8.8M Q2 '24: -6.3M Q3 '24: -6.2M Q4 '24: -5.8M Q1 '25: -5.1M Q2 '25: -4.8M Q3 '25: -4.5M Q4 '25: -6.3M Q1 '26: -7.7M Q2 '26: -9.2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-200M 0 200M 400M 600M Q4 '12: -8.1M Q1 '13: -4M Q2 '13: 5.7M Q3 '13: 71K Q4 '13: 61.5M Q1 '14: 66.1M Q2 '14: 56.3M Q3 '14: 59.8M Q4 '14: 41.6M Q1 '15: 37.1M Q2 '15: 34.9M Q3 '15: 30.6M Q4 '15: -7.6M Q1 '16: -11.3M Q2 '16: -6.8M Q3 '16: -4.7M Q4 '16: 134K Q1 '17: -1.5M Q2 '17: -16.5M Q3 '17: -4.9M Q4 '17: -15.8M Q1 '18: -10.9M Q2 '18: 6.7M Q3 '18: 21.9M Q4 '18: 181.4M Q1 '19: 176.1M Q2 '19: 162.5M Q3 '19: 132.5M Q4 '19: -26.9M Q1 '20: -16.7M Q2 '20: -14.5M Q3 '20: 969K Q4 '20: 6.7M Q1 '21: 24.7M Q2 '21: -1.9M Q3 '21: 16.7M Q4 '21: 9.4M Q1 '22: 1.3M Q2 '22: 48.5M Q3 '22: 400.6M Q4 '22: 468.3M Q1 '23: 457.3M Q2 '23: 441.3M Q3 '23: 67.4M Q4 '23: 5.9M Q1 '24: 5M Q2 '24: 5.9M Q3 '24: 3.2M Q4 '24: 5.9M Q1 '25: 7.9M Q2 '25: 6.6M Q3 '25: 5.6M Q4 '25: 13.8M Q1 '26: 9.4M Q2 '26: 8.1M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q4 '12: -24.7M Q1 '13: -24.7M Q2 '13: -40.2M Q3 '13: -41.2M Q4 '13: -66.7M Q1 '14: -90.3M Q2 '14: -66.9M Q3 '14: -60.5M Q4 '14: -29.4M Q1 '15: 16.6M Q2 '15: -58.8M Q3 '15: -63.5M Q4 '15: -50.9M Q1 '16: -79.6M Q2 '16: 25.1M Q3 '16: 10.6M Q4 '16: 2.2M Q1 '17: -645K Q2 '17: -24.2M Q3 '17: -28.6M Q4 '17: -25.1M Q1 '18: -14.2M Q2 '18: -28.4M Q3 '18: -31.7M Q4 '18: -181.2M Q1 '19: -200.5M Q2 '19: -198.1M Q3 '19: -170.2M Q4 '19: -35.7M Q1 '20: -25.9M Q2 '20: -29.4M Q3 '20: -41.7M Q4 '20: 5.6M Q1 '21: 12.5M Q2 '21: 15.5M Q3 '21: 13.7M Q4 '21: -11M Q1 '22: -14.3M Q2 '22: -19M Q3 '22: -9.2M Q4 '22: -45.4M Q1 '23: -39.7M Q2 '23: -46.3M Q3 '23: -32.2M Q4 '23: -31.1M Q1 '24: -28.7M Q2 '24: -19.3M Q3 '24: -21.9M Q4 '25: -2.9M Q1 '26: 1.6M Q2 '26: 2.1M Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '21 Q3 '23 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 3M 6M 9M Q2 '10: 8.1M Q3 '10: 8.1M Q1 '11: 8.2M Q2 '11: 8.4M Q3 '11: 8.4M Q1 '12: 8.4M Q2 '12: 8.4M Q3 '12: 8.4M Q1 '13: 8.4M Q2 '13: 8.8M Q3 '13: 8.4M Q4 '13: 8.8M Q1 '14: 8.6M Q2 '14: 8.4M Q3 '14: 8.7M Q4 '14: 8.7M Q1 '15: 8.7M Q2 '15: 8.7M Q3 '15: 8.7M Q4 '15: 8.7M Q1 '16: 8.7M Q2 '16: 8.7M Q3 '16: 8.7M Q4 '16: 8.7M Q1 '17: 8.7M Q2 '17: 8.7M Q3 '17: 8.7M Q4 '17: 8.7M Q1 '18: 8.7M Q2 '18: 8.7M Q3 '18: 8.7M Q4 '18: 8.7M Q1 '19: 8.7M Q2 '19: 8.7M Q3 '19: 8.7M Q4 '19: 8.7M Q1 '20: 8.7M Q2 '20: 8.7M Q3 '20: 8.7M Q1 '21: 8.6M Q2 '21: 8.6M Q3 '21: 8.6M Q1 '22: 8.6M Q2 '22: 8.6M Q3 '22: 8.6M Q1 '23: 8.6M Q2 '23: 8.6M Q3 '23: 8.6M Q1 '24: 8.6M Q2 '24: 8.6M Q3 '24: 8.6M Q1 '25: 8.6M Q2 '25: 8.6M Q3 '25: 8.6M Q1 '26: 8.6M Q2 '26: 8.6M Q2 '12 Q2 '14 Q1 '16 Q4 '17 Q3 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q4 '10: -8.41 Q1 '11: -8.58 Q2 '11: -7.76 Q3 '11: -6.55 Q4 '11: -5.67 Q1 '12: -4.73 Q2 '12: -2.78 Q3 '12: -2.92 Q4 '12: -1.13 Q1 '14: 7.37 Q2 '14: 6.29 Q3 '14: 6.74 Q4 '14: 4.66 Q1 '15: 4.15 Q2 '15: 3.89 Q3 '15: 3.39 Q4 '15: -0.99 Q1 '16: -1.40 Q2 '16: -0.88 Q3 '16: 0.46 Q4 '16: 1.00 Q1 '17: 0.82 Q2 '17: -0.91 Q3 '17: -0.67 Q4 '17: -1.92 Q1 '18: -1.36 Q2 '18: 0.67 Q3 '18: 2.40 Q4 '18: 20.72 Q1 '19: 20.13 Q2 '19: 18.59 Q3 '19: 15.18 Q4 '19: -3.09 Q1 '20: -1.92 Q2 '20: -1.67 Q3 '20: 0.10 Q4 '20: 0.76 Q1 '21: 2.85 Q2 '21: -0.23 Q3 '21: 1.93 Q4 '21: 1.09 Q1 '22: 0.15 Q2 '22: 5.62 Q3 '22: 46.37 Q4 '22: 54.20 Q1 '23: 52.93 Q2 '23: 51.08 Q3 '23: 7.81 Q4 '23: 0.69 Q1 '24: 0.58 Q2 '24: 0.69 Q3 '24: 0.37 Q4 '24: 0.68 Q1 '25: 0.91 Q2 '25: 0.76 Q3 '25: 0.64 Q4 '25: 1.60 Q1 '26: 1.09 Q2 '26: 0.94 Q2 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.